Literature DB >> 9382729

Mucosal immunity--a major adaptive defence mechanism.

P Brandtzaeg1, A E Berstad, I N Farstad, G Haraldsen, L Helgeland, F L Jahnsen, F E Johansen, I B Natvig, E M Nilsen, J Rugtveit.   

Abstract

The epithelial glycoprotein called secretory component (SC) is quantitatively the most important receptor of the immune system because it is responsible for external transport of locally produced polymeric IgA (pIgA) to generate remarkably large amounts of secretory IgA. Antibodies of this type constitute the major mediators of specific humoral immunity. Transmembrane SC belongs to the Ig supergene family and functions as a common pIg receptor, also translocating pentameric IgM externally to form secretory IgM. The B cells responsible for mucosal pIg production are initially stimulated in organized mucosa-associated lymphoepithelial structures, particularly the Peyer's patches in the distal small intestine; from these inductive site they migrate as memory cells to exocrine tissues all over the body. Mucous membranes are thus furnished with secretory antibodies in an integrated way, ensuring a variety of specificities at every secretory effector site. There is currently great interest in exploiting this integrated or "common" mucosal immune system for oral vaccination against pathogenic infectious agents and also to induce tolerance in T cell-mediated autoimmune diseases. However, much remains to be learned about mechanisms for antigen uptake and processing necessary to elicit stimulatory or suppressive mucosal immune responses. Moreover, evidence is emerging for the existence of considerable regionalization with regard to functional links between inductive sites and effecter sites of mucosal immunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9382729

Source DB:  PubMed          Journal:  Behring Inst Mitt        ISSN: 0301-0457


  6 in total

1.  [Eye-associated lymphoid tissue (EALT) is continuously spread throughout the ocular surface from the lacrimal gland to the lacrimal drainage system].

Authors:  E Knop; N Knop
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

2.  Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.

Authors:  Justin L Spinner; Hardeep S Oberoi; Yvonne M Yorgensen; Danielle S Poirier; David J Burkhart; Martin Plante; Jay T Evans
Journal:  Vaccine       Date:  2015-09-21       Impact factor: 3.641

3.  Expression of major histocompatibility complex class II and CD80 by gingival epithelial cells induces activation of CD4+ T cells in response to bacterial challenge.

Authors:  Takashi Matsuyama; Toshihisa Kawai; Yuichi Izumi; Martin A Taubman
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Loading of tetanus toxoid to biodegradable nanoparticles from branched poly(sulfobutyl-polyvinyl alcohol)-g-(lactide-co-glycolide) nanoparticles by protein adsorption: a mechanistic study.

Authors:  Tobias Jung; Walter Kamm; Armin Breitenbach; Gerhard Klebe; Thomas Kissel
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

Review 5.  Food fight! Parenteral nutrition, enteral stimulation and gut-derived mucosal immunity.

Authors:  Joshua L Hermsen; Yoshifumi Sano; Kenneth A Kudsk
Journal:  Langenbecks Arch Surg       Date:  2008-06-03       Impact factor: 3.445

6.  Modulation by colostrum-acquired maternal antibodies of systemic and mucosal antibody responses to rotavirus in calves experimentally challenged with bovine rotavirus.

Authors:  V Parreño; C Béjar; A Vagnozzi; M Barrandeguy; V Costantini; M I Craig; L Yuan; D Hodgins; L Saif; F Fernández
Journal:  Vet Immunol Immunopathol       Date:  2004-07       Impact factor: 2.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.